Pseudouridine reprogramming in the human T-cell epitranscriptome: from primary to immortalized states
RNA · 2025
DOI: 10.1261/rna.080633.125 ↗Kurz gefasst
Fachartikel in der Zeitschrift RNA, 2025. Verfasst von Oleksandra Fanari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Northeastern University, Boston, Massachusetts 02120, USA. Hauptthemen laut MEDLINE: T-Lymphocytes, Pseudouridine, Transcriptome, RNA Processing, Post-Transcriptional. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS.
Abstract (Originalsprache)
Immortalized cell lines are commonly used as proxies for primary cells in human biology research. For example, Jurkat leukemic T cells fundamentally contributed to uncovering T-cell signaling, activation, and immune responses. However, the immortalization process can alter key cellular properties, and researchers widely believe this process could significantly change RNA modification machinery and modification sites. In this study, we focus on pseudouridine (ψ), one of the most abundant mRNA modifications, and compare ψ profiles in mRNA from primary and immortalized T cells using direct RNA sequencing (DRS). Surprisingly, 87% of ψ-sites were shared between the two cell types, primarily in transcripts encoding proteins involved in essential cellular processes, including RNA-modification regulation. Furthermore, the analysis of the 13% of sites unique to each cell type reveals that Jurkat cells contained transcripts linked to immune activation and oncogenesis, while primary T cells contained transcripts associated with calcium signaling and intracellular trafficking. We provide a list of these genes, which should be considered when using immortalized cells to study RNA modifications in immunology contexts. Most differences were driven by whether the mRNA was present or absent in the immortalized or primary cell type. Interestingly, RNA-modification enzyme expression levels were highly conserved in both cell types. This suggests that site-specific differences in ψ levels arise from regulatory processes acting in trans rather than differences in modification enzyme levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, Northeastern University, Boston, Massachusetts 02120, USA.
- Department of Physics, Northeastern University, Boston, Massachusetts 02115, USA.
- Department of Bioengineering, Northeastern University, Boston, Massachusetts 02120, USA s.rouhanifard@northeastern.edu.
ORCID-Profile: Oleksandra Fanari, Dylan Bloch, Yuchen Qiu, Michele Meseonznik, Amr Makhamreh, Meni Wanunu, Sara H Rouhanifard
Förderung
- NHGRI NIH HHS
Zitieren
APA
Fanari, O., Bloch, D., Qiu, Y., Meseonznik, M., Boyko, D., Makhamreh, A., Wanunu, M., & Rouhanifard, S. H. (2025). Pseudouridine reprogramming in the human T-cell epitranscriptome: from primary to immortalized states. RNA. https://doi.org/10.1261/rna.080633.125
Vancouver
Fanari O, Bloch D, Qiu Y, Meseonznik M, Boyko D, Makhamreh A, et al. Pseudouridine reprogramming in the human T-cell epitranscriptome: from primary to immortalized states. RNA. 2025. doi:10.1261/rna.080633.125
BibTeX
@article{Fanari2025,
author = {Fanari, Oleksandra and Bloch, Dylan and Qiu, Yuchen and Meseonznik, Michele and Boyko, Dinara and Makhamreh, Amr and Wanunu, Meni and Rouhanifard, Sara H},
title = {Pseudouridine reprogramming in the human T-cell epitranscriptome: from primary to immortalized states},
journal = {RNA},
year = {2025},
doi = {10.1261/rna.080633.125}
}
EUVIMED